Gibson, Dunn & Crutcher is advising Goldman Sachs as financial advisor to Kellanova in the transaction, Skadden, Arps, Slate, Meagher & Flom is advising Mars, with...
Mars’ $36 Billion Acquisition of Kellanova
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...